Key result
In individuals with type 2 diabetes mellitus, adjusting for lipoprotein(a) concentrations revealed a significantly higher risk of cardiovascular mortality in men compared to women (HR 1.53).
Why the study?
Compared to individuals without type 2 diabetes mellitus, the relative increase in cardiovascular mortality is much higher in women than in men.
Does sex and lipoprotein(a) concentration affect cardiovascular mortality in individuals with type 2 diabetes mellitus?
Cohort (n=7,443)
Yes
Does sex and lipoprotein(a) concentration affect cardiovascular mortality in individuals with type 2 diabetes mellitus?
Hazard Ratio: 1.53 (95% CI 1.04–2.24)
Absolute Event Rate: 29.3% vs 25.2%
p-value: p=0.029
Higher lipoprotein(a) concentrations in women with type 2 diabetes mellitus compared to men might partially explain the stronger relative increase in cardiovascular mortality observed in women with T2DM.
Lp(a) adjustment may attenuate observed sex differences in T2DM CV mortality; hypothesis-generating and should not yet change practice.
Background Compared to individuals without type 2 diabetes mellitus, the relative increase in cardiovascular mortality is much higher in women than in men in individuals with type 2 diabetes mellitus. Methods We evaluated data from 7443 individuals (3792 women, 50.9%), aged 20 to 81 years, from two independent population-based investigations, SHIP-0 and MONICA/KORA S3. We analyzed the longitudinal sex-specific associations of lipoprotein(a) with cardiovascular mortality in individuals with and without type 2 diabetes mellitus using Cox regression. Results During a median follow-up of 20.5 years (136,802 person-years), 657 participants (404 men and 253 women) died of cardiovascular causes. Among individuals without type 2 diabetes mellitus, men had a significantly higher risk for cardiovascular mortality compared to women in unadjusted model and after adjustment. On the other hand, in participants with type 2 diabetes mellitus, the risk for cardiovascular mortality was not different between men and women in the unadjusted model and after adjustment for age, body mass index, low-density lipoprotein-cholesterol, fasting status and study sample (SHIP-0, MONICA/KORA S3). Further adjustment for lipoprotein(a) concentrations had no impact on the hazard ratio (HR) for cardiovascular mortality comparing men versus women in individuals without type 2 diabetes mellitus [HR: 1.94; 95% confidence interval (CI) 1.63 to 2.32; p < 0.001]. In individuals with type 2 diabetes mellitus, however, further adjustment for lipoprotein(a) led to an increased risk for cardiovascular mortality in men and a decreased risk in women resulting in a statistically significant difference between men and women (HR: 1.53; 95% CI 1.04 to 2.24; p = 0.029). Conclusions Women are described to have a stronger relative increase in cardiovascular mortality than men when comparing individuals with and without type 2 diabetes mellitus. Higher lipoprotein(a) concentrations in women with type 2 diabetes mellitus than in men with type 2 diabetes mellitus might partially explain this finding.
No takes yet. Share an insight, caveat, or question.
Markus et al. (2021) conducted a cohort in Type 2 diabetes mellitus (n=7,443). Male sex vs. Female sex was evaluated on Cardiovascular mortality in individuals with type 2 diabetes mellitus (adjusted for lipoprotein(a)) (HR 1.53, 95% CI 1.04 to 2.24, p=0.029). In individuals with type 2 diabetes mellitus, adjusting for lipoprotein(a) concentrations revealed a significantly higher risk of cardiovascular mortality in men compared to women (HR 1.53).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: